المؤلفون: Patricia Melgarejo, Natalia Cabrera, Fátima Ovando, Gabriela Avila-Pedretti

المصدر: Revista Paraguaya de Reumatología, Vol 6, Iss 2, Pp 79-84 (2020)

مصطلحات موضوعية: enfermedad de chagas, toxoplasmosis, terapia biológica, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/128Test; https://doaj.org/toc/2413-709XTest; https://doaj.org/toc/2413-4341Test

الوصول الحر: https://doaj.org/article/e8f0cdb5ac62428593522dab582d28eaTest

المؤلفون: Zoilo Morel, Patricia Melgarejo, Marco Franco, Pedro Delgadillo

المصدر: Revista Paraguaya de Reumatología, Vol 4, Iss 2, Pp 52-57 (2018)

مصطلحات موضوعية: vasculitis, poliarteritis nodosa, poliarteritis no- dosa cutánea, adultos, niños, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/91Test; https://doaj.org/toc/2413-709XTest; https://doaj.org/toc/2413-4341Test

الوصول الحر: https://doaj.org/article/4f27ee5117dd4c53af9aa55f50e33834Test

المؤلفون: Patricia Melgarejo, Paloma de Abreu, Clarisse Díaz, Marta Ferreira, Gabriela Ávila-Pedretti, Julio Mazzoleni

المصدر: Revista Paraguaya de Reumatología, Vol 3, Iss 1, Pp 8-14 (2017)

مصطلحات موضوعية: artritis reumatoide, terapia, biológica, análisis de supervivencia, paraguay, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/67Test; https://doaj.org/toc/2413-709XTest; https://doaj.org/toc/2413-4341Test

الوصول الحر: https://doaj.org/article/d3ea03f8acf5436ab6f8b37cb0a4d5c0Test

المؤلفون: Marco Franco, Gabriela Avila Pedretti, Zoilo Morel, Sonia Cabrera Villalba, Patricia Melgarejo, Carmen Martínez, Pedro Babak, Yanira Yinde, Agustina Maidana, Juan Gabriel Elizaur, Teresa Romero de Albrecht, Ernesto Paredes, Julio Mazzoleni

المصدر: Revista Paraguaya de Reumatología, Vol 2, Iss 2, Pp 62-66 (2017)

مصطلحات موضوعية: artritis reumatoide, frecuencia, prescripción, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/38Test; https://doaj.org/toc/2413-709XTest; https://doaj.org/toc/2413-4341Test

الوصول الحر: https://doaj.org/article/8c97753714b64a4f9459a1b94ace8afeTest

المؤلفون: Patricia Melgarejo, Sandra Carolina Acosta Servín, Julio Mazzoleni

المصدر: Revista Paraguaya de Reumatología, Vol 1, Iss 2, Pp 116-119 (2016)

مصطلحات موضوعية: calcifilaxia, úlceras necróticas, enfermedad renal, vasculitis, Internal medicine, RC31-1245, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/25Test; https://doaj.org/toc/2413-709XTest; https://doaj.org/toc/2413-4341Test

الوصول الحر: https://doaj.org/article/a15277b436df4fdaa348b4d9ee05e220Test

المؤلفون: Oriana Betancourt, Karen Villagrán, Fredy Muñoz, Eladio Gutiérrez, Mauricio Mayorga, Patricia Melgarejo

المصدر: Revista Científica, Vol 20, Iss 5 (2010)

مصطلحات موضوعية: L. monocytogenes, longanizas, leche cruda, hortalizas, Cattle, SF191-275, Veterinary medicine, SF600-1100

وصف الملف: electronic resource

العلاقة: http://www.produccioncientificaluz.org/index.php/cientifica/article/view/15596Test; https://doaj.org/toc/0798-2259Test; https://doaj.org/toc/2521-9715Test

الوصول الحر: https://doaj.org/article/032fa6b646754b65ab38ba7218f593f8Test

المؤلفون: Zoilo Morel, Patricia Melgarejo, Marco Franco, Pedro Delgadillo

المصدر: Paraguayan Journal of Rheumatology; Vol. 4 Núm. 2 (2018): Julio-Diciembre; 52-57 ; Revista Paraguaya de Reumatología; Vol. 4 Núm. 2 (2018): Julio-Diciembre; 52-57 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/91/191Test; Watts RA, Robson J. Introduction, epidemiology and classification of vasculitis. Best Pract Res Clin Rheumatol. 2018;32(1):3-20.; Lie JT. Nomenclature and Classification of Vasculitis: plusça change, plus c‘est la même chose. Arthritis Rheum. 1994;37(2):181-6.; Elefante E, Bond M, Monti S, Lepri G, Cavallaro E, Felicetti M, et al. One year in review 2018: systemic vasculitis. Clin Exp Rheumatol. 2018; 36 Suppl 111(2):12- 32. (4) Okazaki T, Shinagawa S, Mikage H. vasculitis syndrome-diagnosis and therapy. J Gen Fam Med. 2017;18(2):72-8.; Chakravarty K, Ong vH, Denton CP. Secondary vasculitis in auto- immune connective tissue diseases. Curr Opin Rheumatol. 2016;28(1):60-5.; Dillon MJ, Eleftheriou D, Brogan PA. Medium-size-vessel vasculitis. Pediatr Nephrol 2010;25(9):1641–52.; Zazueta Montiel B, Flores Suárez LF. Ruta y retos diagnósticos en vasculitis primarias. Reumatol Clin. 2011;7(Suppl 3):S1-6.; Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1-11.; Jennette JC. Overview of the 2012 Revised international Chapel Hill Consensus Conference Nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603-6.; Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, et al. EuLAR/PRiNTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part i: Overall methodology and clinical characterisation. Annals of the Rheumatic Diseases. 2010;69(5):790-7.; Ozen S, Pistorio A, iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EuLAR/PRiNTO/PRES criteria for Henoch-Schonlein purpura, child- hood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classifica- tion criteria. Annals of the Rheumatic Diseases. 2010;69(5):798- 806.; Morel Ayala Z. Clasificación de las Vasculitis Sistémicas en Pediatría. Pediatr (Asunción). 2012;39(2):121-30.; Beckum KM, Kim DJ, Kelly DR, Weiser P, Lara DA, Theos A. Poly- arteritis nodosa in childhood: Recognition of early dermatologic signs may prevent morbidity. Pediatr Dermatol. 2014;31(1):e6–9.; Erden A, Batu ED, Sönmez HE, Sarı A, Armagan B, Arıcı ZS, et al. Comparing polyarteritis nodosa in children and adults: a single center study. int J Rheum Dis. 2017;20(8):1016–22.; Falcini F, Capannini S, Russo G, Battagliese A, D´Amico A, Alessio M. Mycophenolate mofetil treatment in two children with severe polyarteritis nodosa refractory to immunosuppressant drugs. Rheu- matol int. 2012;32(7):2215–9.; Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014;48-49:84–9.; Gomes RC, Marques vL, Cavalcante EG, Campos LM, Sallum AM, Tannuri u, daSilva CA. Severe intestinal involvement as initial manifestation of systemic childhood polyarteritis nodosa: Report of two cases. J Pediatr Surg. 2013;48(2):425-8.; Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, et al. Juvenile polyarteritis: Results of a multicenter survey of 110 child- ren. J Pediatr. 2004;145(4):517–22.; Talukder MK, Islam MI, Rahman SA. Clinical and laboratory profile of childhood polyarteritis nodosa in a Bangladeshi tertiary hospital. Int J Rheum Dis. 2014;17(3):313–6.; De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, et al. Polyarteritis nodosa: A contemporary overview. Autoimmun Rev. 2016;15(6):564- 70.; Iudici M, Puéchal X, Pagnoux C, Quartier P, Agard C, Aouba A, et al. Brief Report: Childhood-Onset Systemic Necrotizing vasculiti- des: Long-Term Data From the French vasculitis Study Group Registry. Arthritis Rheumatol. 2015;67(7):1959-65.; Karadag O, Jayne DJ. Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda. Clin Exp Rheumatol 2018;36 Suppl 111(2):135-42.; Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg- Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore). 2005;84(5):323–30.; Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud‐Ratti v, et al. Short-term corticosteroids then lamivudine and plasma ex- changes to treat hepatitis B virus–related polyarteritis nodosa. Arthritis Rheum. 2004;51(3):482–7.; Stringa MF, Olivera AD, Castro C, Bonavía P, Stringa OJ, Rébora i, Anaya J. Panarteritis nudosa cutánea en la infancia. Arch Argent Pediatr. 2010;108(3):e79– 81.; Williams vL, Guirola R, Flemming K, Modi GM, Rosales C, De Guzman MM. Distal extremity necrosis as a manifestation of cutaneous polyarteritis nodosa: case report and review of the acute management of a pediatric patient. Pediatr Dermatol. 2012;29(4):473–8.; Guillevin L, Cohen P, Mahr A, Arène J-P, Mouthon L, Puéchal X, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing gluco- corticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum. 2003;49(1):93–100.; Seri Y, Shoda H, Hanata N, Nagafuchi Y, Sumitomo S, Jujiko K, Yamamoto K. A case of refractory polyarteritis nodosa successfully treated with rituximab. Mod Rheumatol 2017;27(4): 696-8.; Saunier A, issa N, vandenhende M, Morlat P, Doutre M, Bonnet F. Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?. RMD Open 2017;3e000446.; Matsuo S, Hayashi K, Morimoto E, Kato A, Sada KE, Watanabe H, et al. The successful treatment of refractory polyarteritis nodosa using infliximab. Intern Med 2017;56(11):1435-8.; http://www.revista.spr.org.py/index.php/spr/article/view/91Test

الإتاحة: https://doi.org/10.18004/rpr/2018.04.02.52-57Test
http://www.revista.spr.org.py/index.php/spr/article/view/91Test

المؤلفون: Patricia Melgarejo, Paloma de Abreu, Clarisse Díaz, Marta Ferreira, Gabriela Ávila-Pedretti, Julio Mazzoleni

المصدر: Paraguayan Journal of Rheumatology; Vol. 3 Núm. 1 (2017): Enero-Junio; 8-14 ; Revista Paraguaya de Reumatología; Vol. 3 Núm. 1 (2017): Enero-Junio; 8-14 ; 2413-4341 ; 2413-709X

وصف الملف: application/pdf

العلاقة: http://www.revista.spr.org.py/index.php/spr/article/view/67/166Test; Carmona L, Cross M, Williams B, Lassere M, March L. Rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010 Dec;24(6):733–45.; Kvien TK, Uhlig T, Ødegård S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006 Jun;1069:212–22.; Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, et al. Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatol Oxf Engl. 2012 Jan;51(1): 169–75.; Navarro-Compán V, Moreira V, Ariza-Ariza R, Hernández-Cruz B, V argas-Lebrón C, Navarro-Sarabia F. Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease. Clin Rheumatol. 2011 Jul;30(7):993–6.; Blum MA, Koo D, Doshi JA. Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review. Clin Ther. 2011 Jul;33(7):901–13.; Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–24.; Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: An American C ollege of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep 1;62(9):2569–81.; R Core Team [Internet]. Vienna, Austria: R Foundation for Statistical C omputing, .; 2016. Available from: https://www.R-project.orgTest/.; Markenson JA, Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, et al. Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry. J Rheumatol. 2011 Jul;38(7):1273–81.; Vega Miranda J, Peñaranda P, Fernando L, Muñoz Grajales C, Hernández M, Darío J, et al. Infections in rheumatoid arthritis patients: Biological therapy versus disease modifying anti-rheumatic drugs: One year follow-up. Rev Colomb Reumatol. 2014 Jan;21(1):27–34.; Carmona L. Actualización de BIOBADASER. Reumatol Clínica. 2009;5:66–70.; Curtis JR, Jain A, Askling J, Bridges SL, Carmona L, Dixon W, et al. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis R heum. 2010 Aug;40(1):2–14.e1.; De Abreu Trigueros P. Recomendaciones de la Sociedad Paraguaya de Reumatología sobre el uso de Terapias Biológicas en la Artritis Reumatoide. Rev Paraguaya Reumatol. 2015;1(1):11–8.; Escudero-Vilaplana V, Ramírez-Herraiz E, Trovato-López N, Alañón-Plaza E, Bellini MJ, Herranz-Alonso A, et al. Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2012;15(3):355–60.; Goodyear CS, Tighe H,, McInnes I. Rheumatoid factors and other autoantibodies in rheumatoid arthritis. In: Kelley’s Textbook of R heumatology. 8th ed. Philadelphia: Elsevier; 2009.; Song YW, Kang EH. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM Mon J Assoc Physicians. 2010 Mar;103(3):139–46.; Cui J, Taylor KE, Lee YC, Källberg H, Weinblatt ME, Coblyn JS, et al. The Influence of Polygenic Risk Scores on Heritability of Anti-CCP Level in RA. Genes Immun. 2014 Mar;15(2):107–14.; Ventura-Ríos L, Bañuelos-Ramírez D, Hernández-Quiroz M del C, R obles-San Román M, Irazoque-Palazuelos F, Goycochea-R obles MV. Terapia biológica: sobrevida y seguridad en padecimientos reumáticos. Resultados del Registro Nacional Biobadamex 1.0. Reumatol Clínica. 2012 Jul;8(4):189–94.; De la Vega M, Da Silveira de Carvalho HM, Ventura Rıos L, G oycochea Robles MV, Casado GC. The importance of rheumatology biologic registries in Latin America. Rheumatol Int. 2013;33:827–35.; Kang J-H, Park D-J, Lee J-W, Lee K-E, Wen L, Kim T-J, et al. Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with R heumatoid Arthritis and Ankylosing Spondylitis. J Korean Med Sci. 2014 Sep;29(9):1205–11.; Avila, G, Marsal, S, Alonso, A, Diaz-Mendoza, C, Quesada-Masachs, E. Survival Of Biological Treatment In Chronic Inflammatory Arthritis: A Preliminary Analysis Of 13 Years Of Follow Up In C linical Practice. Arthritis Rheum. 2013;65(suppl 10).; Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, et al. Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival. Semin Arthritis Rheum. 2014 Feb;43(4):447–57.; De la Vega M, Casado G, Roberti J, Gómez M, Benítez A, Battagliotti C, et al. Características de los tratamientos biológicos en enfermedades reumáticas en Argentina: quinto informe del registro BIOBADASAR. Rev Arg Reumatol. 2016;27(1):14–24.; http://www.revista.spr.org.py/index.php/spr/article/view/67Test

الإتاحة: http://www.revista.spr.org.py/index.php/spr/article/view/67Test

المؤلفون: Patricia Melgarejo, Fátima Ovando, Natalia Cabrera, Gabriela Ávila-Pedretti

المصدر: Revista Paraguaya de Reumatología. 6:79-84

مصطلحات موضوعية: Chagas disease, medicine.medical_specialty, education.field_of_study, business.industry, Population, General Medicine, Disease, medicine.disease, Rheumatology, Toxoplasmosis, Serology, Internal medicine, Epidemiology, medicine, Seroprevalence, education, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f44785d03ecc5df9d5f4eeeb93f73e96Test
https://doi.org/10.18004/rpr/2020.06.02.79Test

المؤلفون: Ernesto Paredes, Darwin Octavio Cordovilla, Pedro Delgadillo, Patricia Melgarejo, Gabriela Ávila-Pedretti, S. Cabrera-Villalba, Miguel Albanese, Juan Gabriel Elizaur, Julio Mazzoleni, María Isabel Acosta, Lourdes Román, Zoilo Morel, Paloma de Abreu, Daniel Palleiro, Marco Franco

المصدر: Reumatología Clínica. 16:396-404

مصطلحات موضوعية: Rheumatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3697d00301080c84b40313559dd477d4Test
https://doi.org/10.1016/j.reuma.2018.08.009Test